Please select an option below to help us tailor your newsletter to best suit your content interests!
Brain Cancer patients in the Mid-South now have a promising new treatment method at West Cancer Center, the first of its kind in the region. Optune™, a portable device that uses low intensity electric fields to inhibit cancer cell replication causing death of cancer cells. Optune™ is the first FDA-approved therapy in more than a… Read more »
A new advanced cancer support drug with local ties to Memphis has been approved by the U.S. Food and Drug Administration (FDA). Rolapitant (Varubi™), developed by Tesaro, Inc., has been approved by the FDA for the prevention of chemotherapy-induced nausea and vomiting (CINV). The drug received approval as a result of three phase III clinical… Read more »
Newly formed Memphis Breast Cancer Consortium launches “Sister Pact” – an initiative to encourage regular breast cancer screening, as appropriate, and provide information about local breast health services, such as free or low-cost mammograms. New Community Educational Program Aims to Help Address Breast Cancer Survival Disparity of African-American Women in Memphis Memphis – August 29, 2015 –… Read more »